New data presented at the American Society of Retina Specialists 2024 examine the benefits and adverse event profiles of two ...

It's normal for your eyes to change as you age, but these four expert-approved tips can help improve your eye health.

Current treatments sometimes fail to help people with "wet" age-related macular degeneration-- and researchers now think they ...

Dr. Ali points out that historically, there haven’t been any advanced dry macular degeneration treatment options approved by the FDA. However, that changed in 2023. “The two FDA approved ...

A study from researchers at Wilmer Eye Institute, Johns Hopkins Medicine explains not only why some patients with wet ...

Neuralink Corp., Elon Musk’s brain-computer venture, and rivals like Science Corp. are making strides in technology that ...

Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window GA lesions, which form on the retina due to degeneration of pigment epithelium and photoreceptors, significantly impact ...

"AlloVir and Kalaris enter merger to advance retinal disease therapies" was originally created and published by ...

Sandoz's approval of Afqlir highlights their commitment to affordable, effective treatment options for retinal diseases.

Aflibercept-Biosimilar FYB203 / AHZANTIVE®/ Baiama® receives positive CHMP Opinion from EMA ...

The Healthcare Private Equity team has advised Retina Consultants of America (RCA) and Webster Equity Partners in the sale of ...

Sandoz (SDZNY) said that the European Commission has granted marketing authorization for Afqlir (aflibercept) 2 mg vial kit and ...